Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Hidalgo M, Álvarez R, Gallego J, Guillén-Ponce C, Laquente B, Macarulla T, Muñoz A, Salgado M, Vera R, Adeva J, Alés I, Arévalo S, Blázquez J, Calsina A, Carmona A, de Madaria E, Díaz R, Díez L, Fernández T, de Paredes BG, Gallardo ME, González I, Hernando O, Jiménez P, López A, López C, López-Ríos F, Martín E, Martínez J, Martínez A, Montans J, Pazo R, Plaza JC, Peiró I, Reina JJ, Sanjuanbenito A, Yaya R, Carrato A. Hidalgo M, et al. Clin Transl Oncol. 2017 Jun;19(6):667-681. doi: 10.1007/s12094-016-1594-x. Epub 2016 Dec 19. Clin Transl Oncol. 2017. PMID: 27995549 Free PMC article.
Management of hyperbilirubinaemia in pancreatic cancer patients.
Álvarez R, Carrato A, Adeva J, Alés I, Prados S, Valladares M, Macarulla T, Muñoz A, Hidalgo M. Álvarez R, et al. Among authors: hidalgo m. Eur J Cancer. 2018 May;94:26-36. doi: 10.1016/j.ejca.2018.01.078. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29505968 Review.
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
Van Cutsem E, Hidalgo M, Canon JL, Macarulla T, Bazin I, Poddubskaya E, Manojlovic N, Radenkovic D, Verslype C, Raymond E, Cubillo A, Schueler A, Zhao C, Hammel P. Van Cutsem E, et al. Among authors: hidalgo m. Int J Cancer. 2018 Oct 15;143(8):2053-2064. doi: 10.1002/ijc.31603. Epub 2018 Aug 9. Int J Cancer. 2018. PMID: 29756206 Free article. Clinical Trial.
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.
Macarulla T, Pazo-Cid R, Guillén-Ponce C, López R, Vera R, Reboredo M, Muñoz Martin A, Rivera F, Díaz Beveridge R, La Casta A, Martín Valadés J, Martínez-Galán J, Ales I, Sastre J, Perea S, Hidalgo M. Macarulla T, et al. Among authors: hidalgo m. J Clin Oncol. 2019 Jan 20;37(3):230-238. doi: 10.1200/JCO.18.00089. Epub 2018 Dec 4. J Clin Oncol. 2019. PMID: 30523758 Clinical Trial.
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.
Bockorny B, Macarulla T, Semenisty V, Borazanci E, Feliu J, Ponz-Sarvise M, Abad DG, Oberstein P, Alistar A, Muñoz A, Geva R, Guillén-Ponce C, Fernandez MS, Peled A, Chaney M, Gliko-Kabir I, Shemesh-Darvish L, Ickowicz D, Sorani E, Kadosh S, Vainstein-Haras A, Hidalgo M. Bockorny B, et al. Among authors: hidalgo m. Clin Cancer Res. 2021 Sep 15;27(18):5020-5027. doi: 10.1158/1078-0432.CCR-21-0929. Epub 2021 Jul 12. Clin Cancer Res. 2021. PMID: 34253578 Clinical Trial.
Management of unresectable, locally advanced pancreatic adenocarcinoma.
Salgado M, Arévalo S, Hernando O, Martínez A, Yaya R, Hidalgo M. Salgado M, et al. Among authors: hidalgo m. Clin Transl Oncol. 2018 Feb;20(2):113-118. doi: 10.1007/s12094-017-1679-1. Epub 2017 Jun 13. Clin Transl Oncol. 2018. PMID: 28612202 Review.
Pancreatic ductal adenocarcinoma: metastatic disease.
Muñoz Martín AJ, Adeva J, Martínez-Galán J, Reina JJ, Hidalgo M. Muñoz Martín AJ, et al. Among authors: hidalgo m. Clin Transl Oncol. 2017 Dec;19(12):1423-1429. doi: 10.1007/s12094-017-1690-6. Epub 2017 Jun 16. Clin Transl Oncol. 2017. PMID: 28623515 Review.
Adjuvant treatment for pancreatic ductal carcinoma.
Macarulla T, Fernández T, Gallardo ME, Hernando O, López AM, Hidalgo M. Macarulla T, et al. Among authors: hidalgo m. Clin Transl Oncol. 2017 Oct;19(10):1199-1204. doi: 10.1007/s12094-017-1683-5. Epub 2017 Jun 21. Clin Transl Oncol. 2017. PMID: 28639051 Review.
1,202 results